Human

Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease

Retrieved on: 
Monday, March 4, 2024

MIAMI, March 04, 2024 (GLOBE NEWSWIRE) -- Cyprium Therapeutics, Inc. (“Cyprium”), a majority-owned subsidiary of Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), today announced that the National Institute of Neurological Disorders and Stroke (“NINDS”) of the National Institutes of Health (“NIH”) has awarded a three-year grant totaling approximately $4.1 million to the Research Institute at Nationwide Children’s Hospital and Principal Investigator, Stephen G. Kaler, M.D., M.P.H., to fund completion of preclinical studies, manufacturing and preparation of an Investigational New Drug Application for a first-in-human clinical trial to advance adeno-associated virus (“AAV”)-ATP7A gene therapy, also known as AAV-ATP7A, for the treatment of Menkes disease.

Key Points: 
  • Often lethal if untreated, Menkes disease is an X-linked recessive disorder of copper metabolism caused by mutations in ATP7A, an evolutionarily conserved copper-transporting ATPase.
  • “By combining CUTX-101 with working copies of ATP7A delivered by AAV, we hope to enhance clinical outcomes in Menkes disease, a fatal rare pediatric disease.
  • Preclinical studies have demonstrated a synergistic effect of AAV-ATP7A and CUTX-101 in a reliable mouse model of Menkes disease.
  • In early studies, cerebrospinal fluid (“CSF”)-directed AAV gene therapy rescued 22-53% of mice with a mutation in the human Menkes disease homolog (mottled-brindled) when combined with CSF or subcutaneous copper.

Cerence Names Daniel Tempesta as Chief Financial Officer

Retrieved on: 
Monday, March 4, 2024

(NASDAQ: CRNC), AI for a world in motion, today announced that it has appointed Daniel Tempesta as its new Chief Financial Officer (CFO), effective March 18, 2024.

Key Points: 
  • (NASDAQ: CRNC), AI for a world in motion, today announced that it has appointed Daniel Tempesta as its new Chief Financial Officer (CFO), effective March 18, 2024.
  • Mr. Tempesta brings more than 30 years of financial and operational excellence, as well as extensive knowledge of Cerence from his previous role as CFO of Nuance Communications Inc. (“Nuance”).
  • As Cerence’s CFO, Mr. Tempesta will be focused on accelerating growth, improving operating results, and driving sustainable, long-term value.
  • During his tenure at Nuance, Mr. Tempesta held numerous senior finance roles, including chief accounting officer and senior vice president of finance.

RTA Deploys Fiber-To-The-Premises with DZS Technology to Bring World-Class Broadband Experience to Texas’ Bolivar Peninsula

Retrieved on: 
Monday, March 4, 2024

RTA, which manages more than 13,000 fiber route miles across its 22-state footprint, is upgrading targeted fixed wireless access (FWA) networks to state-of-the-art fiber-to-the-premises (FTTx) access networks.

Key Points: 
  • RTA, which manages more than 13,000 fiber route miles across its 22-state footprint, is upgrading targeted fixed wireless access (FWA) networks to state-of-the-art fiber-to-the-premises (FTTx) access networks.
  • By upgrading its Bolivar Peninsula network to DZS solutions, RTA will be the first to bring fiber-to-the-home (FTTH) and multi-gigabit speeds to more than 6,000 residential and business customers in the region.
  • “DZS is the ideal partner to help us to continue delivering on our mission to bring gigFAST INTERNET communications services to rural communities across America,” said Donald Workman, Chief Operating Officer, RTA.
  • DZS solutions are standards-based, have proven interoperability with most vendors’ equipment and can be readily managed and orchestrated alongside third-party solutions.

Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort

Retrieved on: 
Monday, March 4, 2024

NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, announces positive results from the second cohort of its Phase 1 INDP-D101 trial. Patients continue to exhibit a broad immune response similar to the first cohort. The preliminary results of this study were reviewed by the Company and an independent Safety Review Committee. Based on this review, it was recommended that the Company continue the trial and enroll patients for multiple doses of its lead therapeutic candidate, Decoy20. The company has immediately started screening potential patients.

Key Points: 
  • NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, announces positive results from the second cohort of its Phase 1 INDP-D101 trial.
  • The preliminary results of this study were reviewed by the Company and an independent Safety Review Committee.
  • Jeffrey Meckler, Indaptus’ Chief Executive Officer, commented, “We have now confirmed the safety requirements necessary to advance our Phase 1 trial of Decoy20 to multi-dosing.
  • We look forward to seeing how patients in this cohort tolerate and respond to Decoy20, which will also be instructive as we progress toward Phase 2.”

A.I. Supercomputer Market Projected To Reach $3.3 Billion By 2028 with Significant Growth Expected

Retrieved on: 
Monday, March 4, 2024

A report from MarketsAndMarkets said that the AI supercomputer market is projected to grow from USD $1.2 billion in 2023 and is expected to reach USD $3.3 billion by 2028, growing at a CAGR of 22.0% from 2023 to 2028.

Key Points: 
  • A report from MarketsAndMarkets said that the AI supercomputer market is projected to grow from USD $1.2 billion in 2023 and is expected to reach USD $3.3 billion by 2028, growing at a CAGR of 22.0% from 2023 to 2028.
  • The report said: “The Government segment in the AI supercomputer market for application is expected to hold the largest market size during the forecast period in the AI supercomputer market.
  • Moreover, AI supercomputers are also being used to coordinate disaster relief efforts and provide assistance to victims of disasters.
  • AI supercomputers process vast datasets in real time, providing valuable insights into customer behavior, market trends, and operational efficiency.

PodcastOne (NASDAQ: PODC) Acquires Exclusive Rights to Jackie Schimmel's The Bitch Bible Podcast, Further Strengthening PodcastOne’s Thriving Network of Female Focused Programming

Retrieved on: 
Monday, March 4, 2024

LOS ANGELES, CA, March 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – PodcastOne (NASDAQ: PODC), a leading podcast platform and a subsidiary of LiveOne (NASDAQ: LVO), which owns ~73% of the PODC outstanding common stock, announced today that it has acquired the exclusive sales and distribution rights to Jackie Schimmel’s The Bitch Bible Podcast. This acquisition allows the podcast to immediately become a cornerstone of PodcastOne’s flourishing and growing network of programming for women.

Key Points: 
  • This acquisition allows the podcast to immediately become a cornerstone of PodcastOne’s flourishing and growing network of programming for women.
  • As part of the newly announced partnership, Schimmel will begin to create video elements as a companion to her audio-based podcast.
  • “PodcastOne is thrilled to welcome Jackie and The Bitch Bible to the network.
  • PodcastOne shows are available through PodcastOne , Apple Podcasts, Spotify, iHeart, Amazon and wherever podcasts are heard.

COFACE SA launches Power the Core, its 2024-2027 strategic plan with a view to develop a global ecosystem of reference for credit risk management

Retrieved on: 
Monday, March 4, 2024

COFACE SA launches Power the Core, its 2024-2027 strategic plan with a view to develop a global ecosystem of reference for credit risk management

Key Points: 
  • COFACE SA launches Power the Core, its 2024-2027 strategic plan with a view to develop a global ecosystem of reference for credit risk management
    Power the Core will build upon the successes of the previous strategic plans.
  • We have demonstrated that our businesses complement each other, allowing for the development of a credit risk management ecosystem of reference to increase our value proposition to our customers.
  • Our new plan Power the Core aims at building upon our strengths and our employees’ commitment and expertise in order to accelerate our transformation.
  • We will in particular deliberately invest in data and technology, for our Trade Credit Insurance and our Business Information services.

Ibogaine By David Dardashti Visits Ohio to Explore Economic Benefits

Retrieved on: 
Sunday, March 3, 2024

BOSTON, March 03, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, an organization focusing on providing ibogaine treatment to those afflicted with opiate addiction, recently visited Ohio to explore the potential economic benefits if the state were to legalize the substance.

Key Points: 
  • BOSTON, March 03, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, an organization focusing on providing ibogaine treatment to those afflicted with opiate addiction, recently visited Ohio to explore the potential economic benefits if the state were to legalize the substance.
  • "Ibogaine Legislation" Led by David Dardashti, a successful real estate entrepreneur since his 26th year, and Chief Operations Officer Cole Barressi, Ibogaine By David Dardashti flew out to Cleveland to discuss potential opportunities that would arise if the state of Ohio were to pass ibogaine legislation.
  • Ibogaine By David Dardashti is advocating for the legalization of ibogaine in Ohio in order to provide seamless access to treatment for all people, regardless of socioeconomic status.
  • Ibogaine By David Dardashti encourages those suffering from opiate addiction to speak to their lawmakers and voice their support for the legalization of ibogaine in the state of Ohio.

CJ FOODS MANUFACTURING BEAUMONT CORPORATION RECALLS TRADER JOE’S CHICKEN SOUP DUMPLINGS DUE TO POSSIBLE FOREIGN MATTER CONTAMINATION

Retrieved on: 
Saturday, March 2, 2024

boxes with plastic trays containing six pieces of “TRADER JOE’S Steamed Chicken Soup Dumplings” with lot codes “03.07.25.C1-1” and “03.07.25.C1-2” printed on the side of the box.

Key Points: 
  • boxes with plastic trays containing six pieces of “TRADER JOE’S Steamed Chicken Soup Dumplings” with lot codes “03.07.25.C1-1” and “03.07.25.C1-2” printed on the side of the box.
  • The problem was discovered after the firm received complaints from consumers reporting they found hard plastic in Trader Joe’s steamed chicken soup dumplings.
  • Consumers with questions about the recall can contact the CJ Foods Manufacturing Beaumont Corporation’s Consumer Experience Department at 800-544-6855.
  • Members of the media with questions can contact CJ Foods Manufacturing Beaumont Corporation's media relations team at 507-537-8550 or [email protected].

Readout of SBA Administrator Guzman’s Attendance at White House Roundtable on Increasing Capital Access for Tribal Nations

Retrieved on: 
Friday, March 1, 2024

At the roundtable, Administrator Guzman underscored the SBA’s commitment to increasing capital access for Native Americans as part of President Biden’s Investing in America Agenda.

Key Points: 
  • At the roundtable, Administrator Guzman underscored the SBA’s commitment to increasing capital access for Native Americans as part of President Biden’s Investing in America Agenda.
  • Under the Biden-Harris Administration, total loans to Native-owned businesses are up 70% , and total loan dollars have almost doubled.
  • The roundtable acknowledged that while significant progress has been made, there is still more work to be done as the Biden-Harris Administration strives to better serve Tribal communities.
  • For follow-up interview requests for Administrator Guzman, please contact Rebecca Galanti at [email protected] .